Synonyms: Ceflatonin; cephalotaxine; Ceflatonin; HHT; Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester); Cephalotaxine, O3-((2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methyl-1-oxoheptyl)-; (3beta)-O~3~-[(2r)-2,6-Dihydroxy-2-(2-Methoxy-2-Oxoethyl)-6-Methylheptanoyl]cephalotaxine; 64131-12-0; Cephalotaxine, 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester), [3(R)]-; 26833-87-4; Myelostat; CGX-635; Omapro; (-)-homoharringtonine; UNII-6FG8041S5B; NSC-141633; (2'R,3S,4S,5R)-(-)-homoharringtonine; CHEBI:71019; homoharringtonine; 6FG8041S5B; NSC 141633; cephalotaxine 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate; C29H39NO9; Omacetaxine; Tekinex; BRN 5687925; Synribo (TN); Homoharringtonin; NSC141633; Homoharringtonine (3(R))-isomer; NCGC00025155-01; Omacetaxine mepesuccinate [USAN:INN]; omacetaxini mepesuccinas; AC1Q5YWQ; Homoharringtonine (8CI); ZJ-C; mepesuccinate d'omacetaxine; mepesuccinato de omacetaxina; MLS001424293; CHEMBL46286; Omacetaxine; Omacetaxine (homoharringtonine); CGX-635-14 (formulation); GTPL7454; SCHEMBL12745687; CTK8E8620; CGX 635; Omacetaxine mepesuccinate (USAN); Cephalotaxine, 4-methyl-, 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester); HYFHYPWGAURHIV-JFIAXGOJSA-N; HMS3267H22; omacetaxine mepesuccinate; HMS3678N03; AC1L6273; BCP28190; Homoharringtonine, >=98% (HPLC); MFCD05618221; ZINC26011099; AKOS024456585; ACN-035229; CS-2872; DB04865; Synribo; NC00395; Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (Ester); o3-[(2r)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methylheptanoyl]cephalotaxine; NCGC00025155-02; NCGC00025155-03; NCGC00025155-04; HY-14944; NCI60_000917; SAM001246822; SMR000469230; homoharringtonine; ST056357; AB0019750; TR-031859; Homoharringtonine|||Omacetaxine mepesuccinate; N1504; V0232; D08956; AB00642561-02; SR-01000597562; SR-01000597562-1; Omacetaxine mepesuccinate; BRD-K76674262-001-01-7; BRD-K76674262-001-02-5; [3(R)]-4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate; Cephalotaxine 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate; (2S,3S,6S)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.0<2,6>.0<6,10>.0<15,1 9>]icosa-1(20),4,13,15(19)-tetraen-3-yl methyl (2R)-2-hydroxy-2-(4-hydroxy-4-m ethylpentyl)butane-1,4-dioate; 1-((1S,3aR,14bS)-2-Methoxy-1,5,6,8,9,14b-hexahydro-4H- cyclopenta(a)(1,3)dioxolo(4,5-h)pyrrolo(2,1-b)(3)benzazepin-1-yl) 4-methyl (2R)-2- hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate; Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester) (9CI); Cephalotaxine, 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester), (3(R))- (9CI); Cephalotaxine; D0M4XY; Synribo; Cephalotaxine, [3(R)]-; Homoharringtonine (3(R))-isomer; Omacetaxine mepesuccinate [USAN]; AR-1K8685; C29-H39-N-O9; CID285033; CPD000469230; homoharringtonine, 3H-labeled, (3(R))-isomer; C001652; D000077863;